Stephens Inc. AR Has $301,000 Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Stephens Inc. AR cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 8.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,274 shares of the medical device company’s stock after selling 296 shares during the period. Stephens Inc. AR’s holdings in Cooper Companies were worth $301,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. CWM LLC lifted its position in Cooper Companies by 35.8% during the 3rd quarter. CWM LLC now owns 5,193 shares of the medical device company’s stock worth $573,000 after buying an additional 1,370 shares in the last quarter. Exchange Traded Concepts LLC acquired a new stake in shares of Cooper Companies in the third quarter valued at about $121,000. Vontobel Holding Ltd. raised its holdings in Cooper Companies by 7.8% during the third quarter. Vontobel Holding Ltd. now owns 5,208 shares of the medical device company’s stock worth $575,000 after acquiring an additional 377 shares in the last quarter. Bleakley Financial Group LLC boosted its position in Cooper Companies by 2.1% during the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock valued at $636,000 after purchasing an additional 119 shares during the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in Cooper Companies by 2.3% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 32,354 shares of the medical device company’s stock valued at $3,570,000 after purchasing an additional 715 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $88.10 on Friday. The firm has a market cap of $17.58 billion, a P/E ratio of 45.18, a price-to-earnings-growth ratio of 2.41 and a beta of 1.00. The business’s 50 day moving average is $93.94 and its 200-day moving average is $99.78. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.87 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

COO has been the topic of a number of analyst reports. Morgan Stanley dropped their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Citigroup cut their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Wells Fargo & Company raised their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Finally, StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.